{
    "nctId": "NCT04880369",
    "briefTitle": "Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression",
    "officialTitle": "DAGMAR: Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, Breast Neoplasms, Breast Cancer Female",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Ki-67",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with breast cancer at \"Brystkirurgisk Afdeling\" at Rigshospitalet and Herlev Hospitals (within the last 30 days).\n* Advised (and accepted) to receive neo-adjuvant treatment\n* Primary unilateral breast cancer\n* Treatment is expected to be curative\n* Is expected to be able to attend surgery\n\nExclusion Criteria:\n\n* Allergic to soy\n* Celiac disease\n* Inflammatory bowel disease\n* Not understanding Danish (patient material and questionnaires are in Danish)\n* Prior diagnosis of breast cancer\n* Use of dietary supplements containing lignans or isoflavones three months prior to diagnosis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}